JOURNAL OF CLINICAL SURGERY ›› 2020, Vol. 28 ›› Issue (6): 551-553.doi: 10.3969/j.issn.1005-6483.2020.06.015
Previous Articles Next Articles
Online:
Published:
Abstract: Objective:To evaluate the feasibility and tumor safety of ARM in SLNB or ALND surgery,and to provide reference for determining its accurate indication.Methods:ARM lymph nodes were imaged with 2 ml indocyanine green solution and sentinel lymph nodes were imaged with methylene blue solution 2ml with 5mg/ml concentration.Axillary lymph node dissection was performed in all patients.Results:Among 117 patients,94 patients were ≤ N1 stage,accounting for 80.4%.ARM lymph nodes were detected in 100 patients with a total detection rate of 85.5%,and in 90 patients with stage ≤ N1,the detection rate was 96%.ARMSLN overlapping patients were detected in 3 patients,including 2 patients with stage N2 and 1 patient with stage N3,and 9 patients with ARM metastasis(7.7%).Conclusion:ARM operation is feasible and relatively safe for breast cancer patients with axillary stage ≤ n 1,and can be popularized.The case data of patients with stage ≥ N2 are few,so more studies are needed to subdivide them to find out the suitable indications for ARM operation,while ARM operation is not recommended for patients with neoadjuvant chemotherapy.
Key words: breast cancer, axillary lymph node dissection, inverse axillary lymph node mapping, indocyanine green, sentinel node
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://www.lcwkzz.com/EN/10.3969/j.issn.1005-6483.2020.06.015
http://www.lcwkzz.com/EN/Y2020/V28/I6/551
Cited